Argenx
ARGX
#499
Rank
โ‚น4.822 T
Marketcap
โ‚น77,162
Share price
-1.20%
Change (1 day)
55.76%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,513. In 2024 the company made an earnings per share (EPS) of โ‚น1,332 an increase over its 2023 EPS that were of -โ‚น493.71.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415
2024โ‚น1,332-369.77%
2023-โ‚น493.71-60.46%
2022-โ‚น1,24963.33%
2021-โ‚น764.48-40.37%
2020-โ‚น1,282183.47%
2019-โ‚น452.29123.09%
2018-โ‚น202.7454.93%
2017-โ‚น130.8614.07%
2016-โ‚น114.7113.05%
2015-โ‚น101.47-36.34%
2014-โ‚น159.40209.04%
2013-โ‚น51.58-33.99%
2012-โ‚น78.14185.59%
2011-โ‚น27.36